INHIBITION OF HUMAN ERYTHROID COLONY-FORMING-UNITS BY INTERLEUKIN-1 IS MEDIATED BY GAMMA-INTERFERON

被引:137
作者
MEANS, RT [1 ]
DESSYPRIS, EN [1 ]
KRANTZ, SB [1 ]
机构
[1] VANDERBILT UNIV,SCH MED,NASHVILLE,TN 37212
关键词
D O I
10.1002/jcp.1041500109
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
IL-1 inhibits erythropoiesis in vivo and in vitro. This inhibition was studied by comparing the effect of recombinant human IL-1 (rhIL-1) on highly purified CFU-erythroid (E) generated from peripheral blood burst-forming units-erythroid (BFU-E) (mean purity 44.4%) with its effect on unpurified marrow CFU-E (mean purity 0.36%). Colony formation by marrow CFU-E was significantly inhibited by rhIL-1, while colony formation by highly purified CFU-E was not inhibited. However, purified CFU-E colonies were inhibited by rhIL-1 in the presence of autologous T-lymphocytes, and also by cell-free conditioned medium prepared from T-lymphocytes stimulated by rhIL-1. This inhibitory effect was ablated by neutralizing antibodies to gamma-interferon (IFN), but not by antibodies to human IL-1, tumor necrosis factor, or beta-IFN. Colony formation by highly purified CFU-E was also inhibited by recombinant human gamma-IFN (rh-gamma-IFN). IL-1 and gamma-IFN play significant roles in the pathogenesis of the anemia of chronic disease. These studies indicate that rhIL-1 inhibits CFU-E colony formation by an indirect mechanism involving T-lymphocytes and requiring gamma-IFN and that gamma-IFN itself is most probably the direct mediator of this effect.
引用
收藏
页码:59 / 64
页数:6
相关论文
共 26 条
[21]   INHIBITION BY INTERLEUKIN-1 OF THE ACTION OF ERYTHROPOIETIN ON ERYTHROID PRECURSORS AND ITS POSSIBLE ROLE IN THE PATHOGENESIS OF HYPOPLASTIC ANEMIAS [J].
SCHOOLEY, JC ;
KULLGREN, B ;
ALLISON, AC .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 67 (01) :11-17
[22]  
STORK LC, 1988, EXP HEMATOL, V16, P163
[23]  
SUGIMOTO M, 1989, AM J HEMATOL, V25, P1
[24]   PHASE-I TRIAL OF RECOMBINANT INTERFERON-GAMMA IN CANCER-PATIENTS [J].
VADHANRAJ, S ;
ALKATIB, A ;
BHALLA, R ;
PELUS, L ;
NATHAN, CF ;
SHERWIN, SA ;
OETTGEN, HF ;
KROWN, SE .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) :137-146
[25]  
ZOUMBOS NC, 1990, EUR J HAEMATOL, V44, P282
[26]  
ZOUMBOS NC, 1984, J IMMUNOL, V133, P769